fluoxetine has been researched along with Dizziness in 21 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Dizziness: An imprecise term which may refer to a sense of spatial disorientation, motion of the environment, or lightheadedness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study is to investigate the clinical therapeutic effects and safety of treating mild or moderate depression with somatic symptoms with electroacupuncture combined with Fluoxetine." | 9.14 | Efficacy evaluation for depression with somatic symptoms treated by electroacupuncture combined with Fluoxetine. ( Chen, LP; Duan, DM; Tu, Y; Wu, ZJ, 2009) |
| "Fluoxetine, a specific serotonin reuptake inhibitor, was compared to amitriptyline in the treatment of 51 outpatients with primary major depressive disorder." | 9.05 | A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. ( Chouinard, G, 1985) |
| "The efficacy and safety of fluoxetine, a new antidepressant agent, were assessed in a double-blind, parallel, randomized study of 44 outpatients with major depressive disorder." | 9.05 | A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. ( Feighner, JP, 1985) |
| "Fluoxetine was compared to doxepin in geriatric out-patients with major depressive illness." | 6.66 | Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. ( Cohn, JB; Feighner, JP, 1985) |
| "This study is to investigate the clinical therapeutic effects and safety of treating mild or moderate depression with somatic symptoms with electroacupuncture combined with Fluoxetine." | 5.14 | Efficacy evaluation for depression with somatic symptoms treated by electroacupuncture combined with Fluoxetine. ( Chen, LP; Duan, DM; Tu, Y; Wu, ZJ, 2009) |
| " For individual adverse events that developed or worsened during therapy, more fluoxetine-treated patients reported rhinitis and tremor (p less than or equal to ." | 5.07 | Fluoxetine versus trazodone: efficacy and activating-sedating effects. ( Beasley, CM; Bosomworth, JC; Dornseif, BE; Pultz, JA; Sayler, ME, 1991) |
| "Fluoxetine, a specific serotonin reuptake inhibitor, was compared to amitriptyline in the treatment of 51 outpatients with primary major depressive disorder." | 5.05 | A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. ( Chouinard, G, 1985) |
| "The efficacy and safety of fluoxetine, a new antidepressant agent, were assessed in a double-blind, parallel, randomized study of 44 outpatients with major depressive disorder." | 5.05 | A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. ( Feighner, JP, 1985) |
| "Outpatients with recurrent unipolar depression (DSM-IV criteria; N = 1096) were randomly assigned in a 3:1 ratio to 10 weeks of treatment with venlafaxine ER or fluoxetine." | 2.73 | The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. ( Ahmed, S; Dunner, DL; Ferguson, JM; Friedman, ES; Gelenberg, AJ; Hirschfeld, RM; Keller, MB; Kocsis, JH; Kornstein, SG; Musgnung, J; Nemeroff, CB; Ninan, PT; Pedersen, RD; Rothschild, AJ; Schatzberg, AF; Shelton, RC; Thase, ME; Trivedi, MH; Yan, B; Zajecka, JM, 2007) |
| "Selective serotonin reuptake inhibitors may be associated with new adverse events after abrupt discontinuation." | 2.69 | Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study. ( Amsterdam, J; Beasley, C; Fawcett, J; Michelson, D; Quitkin, F; Reimherr, F; Rosenbaum, J; Zajecka, J, 1998) |
| "Zolmitriptan was well tolerated when given alone or concomitantly with fluoxetine." | 2.69 | Zolmitriptan (311C90) does not interact with fluoxetine in healthy volunteers. ( Cleary, EW; Huffman, CS; Polvino, WJ; Smith, DA; Watkins, S, 1998) |
| "Fluoxetine and trazodone were compared in a double-blind, randomized, parallel, 6-week trial in 43 outpatients with major depression after a 1-week single-blind placebo period." | 2.66 | Fluoxetine versus trazodone in the treatment of outpatients with major depression. ( Debus, JR; Himmel, C; Polatin, P; Rush, AJ; Tyler, D; Weissenburger, J, 1988) |
| "Fluoxetine was compared to doxepin in geriatric out-patients with major depressive illness." | 2.66 | Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. ( Cohn, JB; Feighner, JP, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (23.81) | 18.7374 |
| 1990's | 11 (52.38) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheehan, DV | 1 |
| Nemeroff, CB | 2 |
| Thase, ME | 2 |
| Entsuah, R | 1 |
| Duan, DM | 1 |
| Tu, Y | 1 |
| Chen, LP | 1 |
| Wu, ZJ | 1 |
| Menza, MA | 1 |
| Dobkin, RD | 1 |
| Marin, H | 1 |
| Keller, MB | 1 |
| Trivedi, MH | 1 |
| Shelton, RC | 1 |
| Kornstein, SG | 2 |
| Friedman, ES | 1 |
| Gelenberg, AJ | 1 |
| Kocsis, JH | 1 |
| Dunner, DL | 1 |
| Hirschfeld, RM | 1 |
| Rothschild, AJ | 1 |
| Ferguson, JM | 1 |
| Schatzberg, AF | 1 |
| Zajecka, JM | 1 |
| Pedersen, RD | 1 |
| Yan, B | 1 |
| Ahmed, S | 1 |
| Musgnung, J | 1 |
| Ninan, PT | 1 |
| Einbinder, E | 1 |
| Shader, RI | 1 |
| Oesterheld, JR | 1 |
| Berlin, CS | 1 |
| Fernández López, MI | 1 |
| Sánchez Esteban, J | 1 |
| Jímenez Belló, J | 1 |
| Meseguer Zaragoza, A | 1 |
| Haddad, P | 1 |
| Zajecka, J | 2 |
| Tracy, KA | 1 |
| Mitchell, S | 1 |
| Fawcett, J | 1 |
| Amsterdam, J | 1 |
| Quitkin, F | 1 |
| Reimherr, F | 1 |
| Rosenbaum, J | 1 |
| Michelson, D | 1 |
| Beasley, C | 1 |
| Benazzi, F | 1 |
| Smith, DA | 1 |
| Cleary, EW | 1 |
| Watkins, S | 1 |
| Huffman, CS | 1 |
| Polvino, WJ | 1 |
| Pollock, BG | 1 |
| Beasley, CM | 1 |
| Dornseif, BE | 1 |
| Pultz, JA | 1 |
| Bosomworth, JC | 1 |
| Sayler, ME | 1 |
| Debus, JR | 1 |
| Rush, AJ | 1 |
| Himmel, C | 1 |
| Tyler, D | 1 |
| Polatin, P | 1 |
| Weissenburger, J | 1 |
| Feighner, JP | 2 |
| Cohn, JB | 2 |
| Wilcox, C | 1 |
| Chouinard, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Acute and Continuation Phase Study of the Comparative Efficacy Study of Venlafaxine ER (Effexor® XR) and Fluoxetine (Prozac®) in Achieving and Sustaining Remission (Wellness) in Patients With Recurrent Unipolar Major Depression; Followed by a Long Term[NCT00046020] | Phase 4 | 1,096 participants (Actual) | Interventional | 2000-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for fluoxetine and Dizziness
| Article | Year |
|---|---|
Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study.
Topics: Adult; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Delayed-Ac | 2008 |
Newer antidepressants and the discontinuation syndrome.
Topics: Adverse Drug Reaction Reporting Systems; Cyclohexanols; Dizziness; Fluoxetine; Headache; Humans; Inc | 1997 |
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Femal | 1997 |
12 trials available for fluoxetine and Dizziness
| Article | Year |
|---|---|
Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features.
Topics: Adult; Antidepressive Agents; Blood Pressure; Constipation; Cyclohexanols; Depressive Disorder, Majo | 2009 |
Efficacy evaluation for depression with somatic symptoms treated by electroacupuncture combined with Fluoxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Depression; Dizziness; D | 2009 |
An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsyc | 2007 |
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depress | 2007 |
Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dizziness; Double-Blind Method | 1998 |
Zolmitriptan (311C90) does not interact with fluoxetine in healthy volunteers.
Topics: Adolescent; Adult; Cranial Sinuses; Cross-Over Studies; Dizziness; Drug Interactions; Drug Tolerance | 1998 |
Fluoxetine versus trazodone: efficacy and activating-sedating effects.
Topics: Adult; Akathisia, Drug-Induced; Ambulatory Care; Anxiety; Depressive Disorder; Dizziness; Double-Bli | 1991 |
Fluoxetine versus trazodone in the treatment of outpatients with major depression.
Topics: Ambulatory Care; Clinical Trials as Topic; Depressive Disorder; Dizziness; Double-Blind Method; Fluo | 1988 |
Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder.
Topics: Age Factors; Aged; Anxiety; Blood Pressure; Body Weight; Clinical Trials as Topic; Depressive Disord | 1985 |
A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
Topics: Adult; Ambulatory Care; Anxiety; Body Weight; Clinical Trials as Topic; Depressive Disorder; Dizzine | 1985 |
A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder.
Topics: Adult; Ambulatory Care; Amitriptyline; Anxiety; Body Weight; Clinical Trials as Topic; Depressive Di | 1985 |
A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
Topics: Adult; Aged; Akathisia, Drug-Induced; Ambulatory Care; Amitriptyline; Clinical Trials as Topic; Depr | 1985 |
6 other studies available for fluoxetine and Dizziness
| Article | Year |
|---|---|
Fluoxetine withdrawal?
Topics: Depressive Disorder; Dizziness; Female; Fluoxetine; Humans; Substance Withdrawal Syndrome | 1995 |
Case 2: Dizzy Giuseppi or the vertiginous virtuoso.
Topics: Aged; Amitriptyline; Depressive Disorder; Dizziness; Dose-Response Relationship, Drug; Drug Administ | 1994 |
Fluoxetine withdrawal symptoms.
Topics: Adult; Anxiety Disorders; Dizziness; Fluoxetine; Humans; Male; Middle Aged; Substance Withdrawal Syn | 1996 |
[Suggestive episodes of hypoglycemia related to fluoxetine].
Topics: Adult; Diabetes Mellitus, Type 2; Diagnosis, Differential; Dizziness; Female; Fluoxetine; Humans; Hy | 1996 |
SSRI discontinuation syndrome treated with fluoxetine.
Topics: Aged; Akathisia, Drug-Induced; Dizziness; Drug Administration Schedule; Female; Fluoxetine; Humans; | 1998 |
Discontinuation symptoms and SSRIs.
Topics: Biological Availability; Depressive Disorder; Dizziness; Fluoxetine; Follow-Up Studies; Half-Life; H | 1998 |